Stocks
Novo Nordisk (NVO) OCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| OCF | ? | 55 000 000 000 | 78 887 000 000 | 108 908 000 000 | 120 968 000 000 | 119 102 000 000 | 118 595 000 000 | ||
| Changes by years, y/y, % | +6% | +43% | +38% | +11% | -2% | +18.0% | |||
Novo Nordisk. OCF
Novo Nordisk. OCF, changes, %
Novo Nordisk. OCF, sum by quarters
Novo Nordisk (NVO) OCF US GAAP (quarter values) |
||||||||
| FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | LTM ? | |||
| OCF | ? | 40 785 000 000 | 46 107 000 000 | 7 619 000 000 | 24 084 000 000 | 55 199 000 000 | 118 595 000 000 | |
| Changes by years, y/y, % | -19% | +5% | -38% | -2% | +35% | |||
| Changes by quarters, q/q, % | +66% | +13% | -83% | +216% | +129% | |||
